BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imwattana K, Kiratisin P, Riley TV, Knight DR. Genomic basis of antimicrobial resistance in non-toxigenic Clostridium difficile in Southeast Asia. Anaerobe 2020;66:102290. [PMID: 33137436 DOI: 10.1016/j.anaerobe.2020.102290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 O’grady K, Knight DR, Riley TV. Antimicrobial resistance in Clostridioides difficile. Eur J Clin Microbiol Infect Dis. [DOI: 10.1007/s10096-021-04311-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Perumalsamy S, Lim SC, Riley TV. Clostridioides (Clostridium) difficile isolated from paediatric patients in Western Australia 2019-2020. Pathology 2022:S0031-3025(22)00020-4. [PMID: 35125203 DOI: 10.1016/j.pathol.2021.10.009] [Reference Citation Analysis]
3 Imwattana K, Rodríguez C, Riley TV, Knight DR. A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile. Microb Genom 2021;7. [PMID: 34793295 DOI: 10.1099/mgen.0.000696] [Reference Citation Analysis]
4 Perumalsamy S, Riley TV. Molecular Epidemiology of Clostridioides difficile Infections in Children. J Pediatric Infect Dis Soc 2021;10:S34-40. [PMID: 34791401 DOI: 10.1093/jpids/piab057] [Reference Citation Analysis]
5 Kartalidis P, Skoulakis A, Tsilipounidaki K, Florou Z, Petinaki E, Fthenakis GC. Clostridioides difficile as a Dynamic Vehicle for the Dissemination of Antimicrobial-Resistance Determinants: Review and In Silico Analysis. Microorganisms 2021;9:1383. [PMID: 34202117 DOI: 10.3390/microorganisms9071383] [Reference Citation Analysis]
6 Imwattana K, Putsathit P, Collins DA, Leepattarakit T, Kiratisin P, Riley TV, Knight DR. Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017. Microb Genom 2022;8. [PMID: 35316173 DOI: 10.1099/mgen.0.000792] [Reference Citation Analysis]